A new study suggests 44% of people with diabetes don't know they have diabetes. The data found that people in sub-Saharan ...

This technology could be used to promote timely lifestyle changes or to design health policies, but experts warn of its ...

Researchers used drug-target Mendelian randomization to test whether genetically proxied activation of GLP1R and GIPR ...

European Association for the Study of Diabetes Opens on September 15Simpler and More Potent... The Race to Develop Obesity ...

Higher semaglutide dose of 7.2 mg was associated with superior weight loss and comparable safety outcomes among patients with obesity.

For children with type 1 diabetes (T1D), glycated hemoglobin (HbA1c) levels are associated with accessibility of modern diabetes technologies and insulin.

The competition to develop obesity treatments that are more convenient and powerful than Wegovy and Mounjaro is intensifying. Since the popularization ...

Distinct metabolic trajectories were associated with differential risks for macrovascular and microvascular complications in prediabetes.

Lee Min-ki, chairman of Seokgyo Trading Co., who celebrated the 40th anniversary of the company’s founding this year, walks ...

Data reveal a growing burden of early-onset type 2 diabetes, highlighting disparities and increased cardiometabolic risk ...

An investigational small-molecule, nonpeptide oral GLP-1 receptor agonist significantly reduced weight in adults with obesity in the randomized ATTAIN-1 trial. At week 72, orforglipron at multiple ...